The age at onset of the disease ranged from 6 to 15 years (mean, 10-4 years). The first symptoms were epileptic seizures (clonic, four patients; myoclonic, three patients; tonic-clonic, two patients; absences, one patient) in 10 patients, action myoclonus in two patients, and cerebellar symptoms in one patient. In all patients, the complete clinical picture included epileptic seizures (clonic, 12 cases; myoclonic, 1 I cases; tonicclonic, 10 cases; absences, three cases) and action or intention myoclonus.
A mild cerebellar syndrome was present in 11 patients. Other findings included pes cavus (three patients), hypopallaesthesia of the lower limbs (two patients), and scoliosis (one patient). Mild intellectual impairment was verified in four patients. The results of funduscopic examination were normal. In all patients, the seizures responded to treatment with sodium valproate or benzodiazepines and diminished in frequency or disappeared with evolution of the disease. Myoclonus was improved or unmodified by treatment in six patients and worsened in seven patients. There was slow deterioration of the cerebellar syndrome in four patients. The mild mental defect verified in four cases did not progress during the course of the illness. Intellect was preserved in the remaining patients over a long term followup period.
At the time of our observations, which were made an average of 16-9 years (range, 7-5 to 37 years) after the onset of the disease, a 32 year old patient who had been affected for 20 Electromyography. Electromyography with determination ofmotor and sensory conduction velocities was performed in six patients, and the results were all normal.
Pathologicalfindings
Biopsy of muscle (deltoid, four patients; quadriceps femoris, six patients; tibialis anterior, two patients; biceps brachii, one patient) was done in all patients an average of 14-2 years (range, 5 5 to 37 years) after the onset of the disease. Light and electron microscopic examinations of the biopsy specimens did not reveal any significant changes. The results of histochemical analysis of the specimens were also normal. Measurement of enzymes in the mitochondrial respiratory chain in four patients showed no abnormalities. Lafora bodies were not found.
Computed tomography and clinical laboratoryfindings
Computed tomography (CT) of the skull was performed in nine patients; except for cerebellar atrophy in one, the scans showed no abnormalities. The results of routine blood and urine tests were normal. Repeated measurement of serum lactate and pyruvate yielded normal values. Activity of lysosomal enzymes in white cells was normal, as was excretion of mucopolysaccharides and oligosaccharides in the urine.
Discussion
The most conspicuous clinical features noted in these 13 generalised epileptic seizures is found in both conditions. In MERRF, however, a constellation of other neurological signs and multisystem abnormalities is usually encountered in various combinations, including the frequent occurrence of deafness, dementia, muscle weakness and atrophy, and ocular abnormalities. It should be emphasised that no case of MERRF has been reported without an additional clinical sign (dementia, deafness, or weakness) associated with the classic triad. In contrast, DCM is devoid of neurological signs other than myoclonus, epilepsy, and cerebellar syndrome. 4. The EEG features of MERRF have been scarcely studied, and only one patient has had a night sleep polygraphic study.'5 The background activity, which is normal or slightly abnormal in DCM, is usually slow in MERRF with or without diffuse slow wave discharges (in the theta or delta range). Spontaneous spike-and-wave discharges have been observed in 100% of DCM cases, but in only 19% of MERRF cases. In addition, photosensitivity has been observed in 85% of DCM cases and 27% of MERRF cases. 5. The evolution of these two conditions is also Tassinari, Michelucci, Genton, Pellissier, Roger different. Ramsay Hunt syndrome carries a relatively good prognosis with excellent seizure control and very slow progression of the cerebellar syndrome and myoclonus. In our group, only one patient was bedridden, and the remaining 12 were minimally or moderately affected an average of 17 years after the onset of the disease. In MERRF, there is often rapid worsening of symptoms and the early occurrence of serious disability. Seven deaths have been reported in the MERRF group, all related to the disease.9 10 12 16 19 21 6. Blood lactate and pyruvate levels are increased in most cases (82%) of MERRF, but are normal in DCM. 7. Results ofmuscle biopsy in our patients with DCM were normal. Although some rare cases of"mitochondrial encephalomyopathy" having normal muscle histology have been described,29 muscle biopsy demonstrates ragged red fibres and clear mitochondrial abnormalities in all cases of MERRF.
The concept of progressive myoclonic epilepsy covers many distinct clinical entities, including DCM, MERRF, Baltic myoclonic epilepsy, cherry-red spot myoclonus syndrome, Lafora's disease, and a variety of other metabolic and genetically determined conditions. 6 The Marseille study27 28 and our current observations demonstrate that DCM is a homogeneous condition characterised by onset in childhood or early adolescence, autosomal recessive inheritance, generalised seizures responsive to therapy, progressive intention or action myoclonus, slowly progressive cerebellar syndrome, and typical EEG and polygraphic findings. When these features are used as diagnostic criteria, DCM may be easily differentiated from MERRF. MERRF is an often progressive and disabling condition with a wide spectrum of age at onset, autosomal dominant or maternal inheritance, epilepsy, myoclonus, and cerebellar syndrome; it is associated with one or more additional neurological signs and distinctive laboratory and pathological findings. However, our study, while it provides sufficient data to differentiate DCM from MERRF, was not intended to discuss the clinical distinctions, if any, between Ramsay Hunt syndrome and other forms of progressive myoclonic epilepsy of unknown aetiology such as Baltic myoclonus. 35 The diagnosis of Ramsay Hunt syndrome has long been considered controversial by many investigators. 35 Indeed, some cases labelled Ramsay Hunt syndrome are often heterogeneous with respect to the clinical features (age at onset, genetic origin, associated symptoms) and the anatomical lesions verified at necropsy. In the light of our findings, however, it is possible that some cases of "DCM", in which the patients have autosomal dominant inheritance,3"33 deafness,333" and other neurological abnormalities3536 were true instances of mitochondrial myopathy, but the pathological findings were not reported. The present study clearly demonstrates that Ramsay Hunt syndrome, as defined by our diagnostic criteria, 27 28 is a condition unrelated to mitochondrial encephalomyopathies.
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